Abstract
The indiscriminate use of antibiotics has been selecting bacterial strains resistant to abroad spectrum of this type of drug. Thus, the development of new antibiotics that act throughpathways that have not yet been explored and, mainly, which are difficult to adapt to bacteria, is ofgreat interest. Polybia-MP-I (MP-I, or simply MP1) is an antimicrobial peptide (AMP) extractedfrom the veno…